Movement Alert｜MEDBOT-B Falls 5.03% in Regular Trading, Profit-Taking Emerges as High Valuation Weighs After Earnings Turnaround

Market Focus07-28

On July 28, MEDBOT-B declined 5.03% in regular trading, trading at HK$20.4/share, with turnover of approximately HK$71.54 million. The sell-off follows sharp rallies of over 10% on July 23 and approximately 7% on July 27, both driven by the company's first-ever half-year profit announcement.

Market analysis indicates the stock's price-to-sales ratio stands at approximately 35x, significantly above global peers such as Medtronic and Stryker, creating elevated profit-taking pressure at current levels. The company announced on July 22 that it expects net profit of RMB 28 million to RMB 40 million for H1, reversing a net loss of RMB 115 million in the prior-year period. Revenue surged 200%-230% year-over-year, driven by its Toumai surgical robot, with overseas revenue growing over 450%. Gross margin improved by more than 15 percentage points.

Within the Health Care Equipment sector, weakness was broad-based, with Lifetech Scientific down 6.62%, MicroPort Scientific down 1.49%, and TH Medical down 1.99%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1186380914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 14:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186380914","market":"us","top_or_hot":-1,"title":"Movement Alert｜MEDBOT-B Falls 5.03% in Regular Trading, Profit-Taking Emerges as High Valuation Weighs After Earnings Turnaround","media":"Market Focus","content":"<p><p>On July 28, MEDBOT-B declined 5.03% in regular trading, trading at HK$20.4/share, with turnover of approximately HK$71.54 million. The sell-off follows sharp rallies of over 10% on July 23 and approximately 7% on July 27, both driven by the company's first-ever half-year profit announcement.</p><p>Market analysis indicates the stock's price-to-sales ratio stands at approximately 35x, significantly above global peers such as Medtronic and Stryker, creating elevated profit-taking pressure at current levels. The company announced on July 22 that it expects net profit of RMB 28 million to RMB 40 million for H1, reversing a net loss of RMB 115 million in the prior-year period. Revenue surged 200%-230% year-over-year, driven by its Toumai surgical robot, with overseas revenue growing over 450%. Gross margin improved by more than 15 percentage points.</p><p>Within the Health Care Equipment sector, weakness was broad-based, with Lifetech Scientific down 6.62%, MicroPort Scientific down 1.49%, and TH Medical down 1.99%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MEDBOT-B Falls 5.03% in Regular Trading, Profit-Taking Emerges as High Valuation Weighs After Earnings Turnaround</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MEDBOT-B Falls 5.03% in Regular Trading, Profit-Taking Emerges as High Valuation Weighs After Earnings Turnaround\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 14:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, MEDBOT-B declined 5.03% in regular trading, trading at HK$20.4/share, with turnover of approximately HK$71.54 million. The sell-off follows sharp rallies of over 10% on July 23 and approximately 7% on July 27, both driven by the company's first-ever half-year profit announcement.</p><p>Market analysis indicates the stock's price-to-sales ratio stands at approximately 35x, significantly above global peers such as Medtronic and Stryker, creating elevated profit-taking pressure at current levels. The company announced on July 22 that it expects net profit of RMB 28 million to RMB 40 million for H1, reversing a net loss of RMB 115 million in the prior-year period. Revenue surged 200%-230% year-over-year, driven by its Toumai surgical robot, with overseas revenue growing over 450%. Gross margin improved by more than 15 percentage points.</p><p>Within the Health Care Equipment sector, weakness was broad-based, with Lifetech Scientific down 6.62%, MicroPort Scientific down 1.49%, and TH Medical down 1.99%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1186380914","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186380914","pubTimestamp":1785220824,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, MEDBOT-B declined 5.03% in regular trading, trading at HK$20.4/share, with turnover of approximately HK$71.54 million. The sell-off follows sharp rallies of over 10% on July 23 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"走势警报|MEDBOT-B 常规交易下跌 5.03%，盈利扭亏为盈后高估值权重出现获利了结","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On July 28, MEDBOT-B declined 5.03% in regular trading, trading at HK$20.4/share, with turnover of approximately HK$71.54 million. The sell-off follows sharp rallies of over 10% on July 23 and approximately 7% on July 27, both driven by the company's first-ever half-year profit announcement.Market analysis indicates the stock's price-to-sales ratio stands at approximately 35x, significantly above global peers such as Medtronic and Stryker, creating elevated profit-taking pressure at current levels. The company announced on July 22 that it expects net profit of RMB 28 million to RMB 40 million for H1, reversing a net loss of RMB 115 million in the prior-year period. Revenue surged 200%-230% year-over-year, driven by its Toumai surgical robot, with overseas revenue growing over 450%. Gross margin improved by more than 15 percentage points.Within the Health Care Equipment sector, weakness was broad-based, with Lifetech Scientific down 6.62%, MicroPort Scientific down 1.49%, and TH Medical down 1.99%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1186380914","isCrawlerRequest":true}